Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Annals of Surgical Oncology
|
June 1, 2017
The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer
Faina Nakhlis, Meredith M Regan, Laura E Warren, et al.
Cancers
|
July 2, 2021
Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (<sup>111</sup>In)/Yttrium 90 (<sup>90</sup>Y) Ibritumomab Tiuxetan (Zevalin<sup>®</sup>) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels
Richard L Wahl, Eric C Frey, Heather A Jacene, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 21, 2025
A pilot study of [<sup>18</sup>F]F-fluciclovine positron emission tomography/computed tomography for staging muscle invasive bladder cancer preceding radical cystectomy
Thomas S C Ng, Mofei Liu, Matthew Robertson, et al.
Melanoma Research
|
September 14, 2018
Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma
Shalin Shah, Jason J Luke, Heather A Jacene, et al.
Practical Radiation Oncology
|
April 24, 2025
Combination Metastasis-Targeted External Beam Radiation Therapy With <sup>177</sup>Lu-PSMA-617 in Patients With Advanced Castration-Resistant Prostate Cancer
Sedra Mohammadi, Isabella R Pompa, Veronica Haberman, et al.
Blood
|
February 21, 2012
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma
Yvette L Kasamon, Heather A Jacene, Christopher D Gocke, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 15, 2019
Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial
Michael J Morris, Yohann Loriot, Christopher J Sweeney, et al.
American Journal of Clinical Oncology
|
June 11, 2020
ACR-ACNM-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With Radium-223
Mark Hurwitz, John R Buscombe, Heather A Jacene, et al.
The Journal of Urology
|
February 29, 2024
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
Todd M Morgan, Stephen A Boorjian, Mark K Buyyounouski, et al.
The Journal of Urology
|
February 29, 2024
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions
Todd M Morgan, Stephen A Boorjian, Mark K Buyyounouski, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Annals of Surgical Oncology
|
June 1, 2017
The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer
Faina Nakhlis, Meredith M Regan, Laura E Warren, et al.
Cancers
|
July 2, 2021
Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (<sup>111</sup>In)/Yttrium 90 (<sup>90</sup>Y) Ibritumomab Tiuxetan (Zevalin<sup>®</sup>) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels
Richard L Wahl, Eric C Frey, Heather A Jacene, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 21, 2025
A pilot study of [<sup>18</sup>F]F-fluciclovine positron emission tomography/computed tomography for staging muscle invasive bladder cancer preceding radical cystectomy
Thomas S C Ng, Mofei Liu, Matthew Robertson, et al.
Melanoma Research
|
September 14, 2018
Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma
Shalin Shah, Jason J Luke, Heather A Jacene, et al.
Practical Radiation Oncology
|
April 24, 2025
Combination Metastasis-Targeted External Beam Radiation Therapy With <sup>177</sup>Lu-PSMA-617 in Patients With Advanced Castration-Resistant Prostate Cancer
Sedra Mohammadi, Isabella R Pompa, Veronica Haberman, et al.
Blood
|
February 21, 2012
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma
Yvette L Kasamon, Heather A Jacene, Christopher D Gocke, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 15, 2019
Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial
Michael J Morris, Yohann Loriot, Christopher J Sweeney, et al.
American Journal of Clinical Oncology
|
June 11, 2020
ACR-ACNM-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With Radium-223
Mark Hurwitz, John R Buscombe, Heather A Jacene, et al.
The Journal of Urology
|
February 29, 2024
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
Todd M Morgan, Stephen A Boorjian, Mark K Buyyounouski, et al.
The Journal of Urology
|
February 29, 2024
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions
Todd M Morgan, Stephen A Boorjian, Mark K Buyyounouski, et al.
Page
of 8